Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lee, Hyunkyoung ^a   Kim, Jong Shu ^a   Kim, Euikyung ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOIDIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG MECHANISM; DRUG TARGETING; FUCUS VESICULOSUS; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS INHIBITION; MIGRATION INHIBITION; SEAWEED; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; FUCUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; POLYSACCHARIDES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

FUCUS VESICULOSUS; MAMMALIA;

EID: 84870615277     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050624     Document Type: Article

References (41)

1. Johnson LL, Dyer R, Hupe DJ, (1998) Matrix metalloproteinases. Curr Opin Chem Biol 2: 466-471.
2. Aisa Y, Miyakawa Y, Nakazato T, Shibata H, Saito K, et al. (2005) Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol 78: 7-14.
3. Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, et al. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212: 489-497.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA: a cancer journal for clinicians 58: 71-96.
5. Westermarck J, Kahari V, (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792.
6. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB, (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
7. Wijesekara I, Pangestuti R, Kim SK, (2010) Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr Polym 84: 14-21.
8. Smit AJ, (2004) Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol 16: 245-262.
9. Zapopozhets TS, Besednova NN, Loenko Iu N, (1995) Antibacterial and immunomodulating activity of fucoidan. Antibiot Khimioter 40: 9-13.
10. Wang J, Zhang Q, Zhang Z, Zhang J, Li P, (2009) Synthesized phosphorylated and aminated derivatives of fucoidan and their potential antioxidant activity in vitro. Int J Biol Macromol 44: 170-174.
11. Choi JI, Raghavendran HR, Sung NY, Kim JH, Chun BS, et al. (2010) Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem Biol Interact 183: 249-254.
12. Durig J, Bruhn T, Zurborn KH, Gutensohn K, Bruhn HD, et al. (1997) Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 85: 479-491.
13. Alekseyenko TV, Zhanayeva SY, Venediktova AA, Zvyagintseva TN, Kuznetsova TA, et al. (2007) Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med 143: 730-732.
14. Ye J, Li Y, Teruya K, Katakura Y, Ichikawa A, et al. (2005) Enzyme-digested Fucoidan Extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniaekylin inhibit invasion and angiogenesis of tumor cells. Cytotechnology 47: 117-126.
15. Kang C, Kim E, (2011) Synergistic effect of curcumin and insulin on muscle cell glucose metabolism. Food Chem Toxicol 48: 2366-2373.
16. Lee KJ, Kim JY, Choi JH, Kim HG, Chung YC, et al. (2006) Inhibition of tumor invasion and metastasis by aqueous extract of the radix of Platycodon grandiflorum. Food Chem Toxicol 44: 1890-1896.
17. Srikantan V, Valladares M, Rhim JS, Moul JW, Srivastava S, (2002) HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res 62: 6812-6816.
18. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, (2001) Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin 3 gallate. Cancer 91: 822-832.
19. Cheng JCH, Chou C, Kuo M, Hsieh C, (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway. Oncogene 25: 7009-7018.
20. Engelman JA, Luo J, Cantley LC, (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
21. Chen J, Wang Q, Fu X, Huang XH, Chen X, et al. (2009) Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 39: 177-186.
22. Easton J, Houghton P, (2006) mTOR and cancer therapy. Oncogene 25: 6436-6446.
23. Viatour P, Merville MP, Bours V, Chariot A, (2005) Phosphorylation of NF-[kappa] B and I [kappa] B proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43-52.
24. Chambers AF, Groom AC, MacDonald IC, (2002) Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572.
25. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C, (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424.
26. Summers JB, Davidsen SK, (1998) Matrix Metalloproteinase Inhibitors and Cancer. Annu Rep Med Chem 33: 131-140.
27. Jung PE, Pezzuto JM, (2002) Botanicals in Cancer Chemoprevention. Cancer Metastasis Rev 21: 231-255.
28. Yamasaki-Miyamoto Y, Yamasaki M, Tachibana H, Yamada K, (2009) Fucoidan induces apoptosis through activation of caspase-8 on human breast cancer MCF-7 cells. J Agric Food Chem 57: 8677-8682.
29. Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS, (2004) Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase plasminogen activator and matrix metalloproteinase 2. Mol Carcinog 40: 143-149.
30. Smalley KSM, (2003) A pivotal role for ERK in the oncogenic behaviour of malignant melanoma. Int J Cancer 104: 527-532.
31. Whitmarsh A, Davis R, (2007) Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26: 3172-3184.
32. Suthiphongchai T, Promyart P, Virochrut S, Tohtong R, Wilairat P, (2003) Involvement of ERK12 in invasiveness and metastatic development of rat prostatic adenocarcinoma. Oncol Res 13: 253-259.
33. Wu WS, Wu JR, Hu CT, (2008) Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev 27: 303-314.
34. Liao D, Wang L, Zhang X, Liu M, (2006) [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer]. Ai zheng = Aizheng = Chin J Cancer 25: 1238-1242.
35. Ye M, Hu D, Tu L, Zhou X, Lu F, et al. (2008) Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci 49: 497-504.
36. Hay N, Sonenberg N, (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
37. Beevers CS, Li F, Liu L, Huang S, (2006) Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J cancer 119: 757-764.
38. Faivre S, Kroemer G, Raymond E, (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5: 671-688.
39. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH, (2006) Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18: 2262-2271.
40. Busch S, Renaud SJ, Schleussner E, Graham CH, Markert UR, (2009) mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res 315: 1724-1733.
41. Bhat-Nakshatri P, Sweeney CJ, Nakshatri H, (2002) Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells. Oncogene 21: 2066-2078.